Gaviscon and Psychotic disorder - a phase IV clinical study of FDA data

Summary:

Psychotic disorder is reported as a side effect among people who take Gaviscon (aluminum hydroxide; magnesium trisilicate), especially for people who are male, 60+ old, also take Lactulose, and have Schizophrenia.

The phase IV clinical study analyzes which people have Psychotic disorder when taking Gaviscon. It is created by eHealthMe based on reports of 11,990 people who have side effects when taking Gaviscon from the FDA, and is updated regularly.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

What is Psychotic disorder?

Psychotic disorder is found to be associated with 1,230 drugs and 1,473 conditions by eHealthMe. Check the latest studies of Psychotic disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

11,990 people reported to have side effects when taking Gaviscon.
Among them, 24 people (0.2%) have Psychotic disorder.

Could Gaviscon cause Psychotic disorder?

Among these 24 people:

What is the gender of people who have Psychotic disorder when taking Gaviscon? *

female: 50 %
male: 50 %

What is the age of people who have Psychotic disorder when taking Gaviscon? *

What are other drugs people take besides Gaviscon? *

Lactulose: 7 people, 29.17%
Acetaminophen: 5 people, 20.83%
Clozaril: 5 people, 20.83%
Desogestrel And Ethinyl Estradiol: 5 people, 20.83%
Disipal: 5 people, 20.83%
Trileptal: 5 people, 20.83%
Omeprazole: 5 people, 20.83%
Stilnoct: 5 people, 20.83%
Orap: 5 people, 20.83%
Seroquel: 5 people, 20.83%

What are other side effects people have besides Psychotic disorder? *

Hallucinations (sensations that appear real but are created by your mind): 8 people, 33.33%
Dizziness: 7 people, 29.17%
Nausea And Vomiting: 6 people, 25.00%
Death: 5 people, 20.83%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 20.83%
Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 5 people, 20.83%
Nightmares (unpleasant dreams): 5 people, 20.83%
Oropharyngeal Pain: 5 people, 20.83%
Hepatic Pain (pain in liver): 5 people, 20.83%
Dyspnea (difficult or laboured breathing): 5 people, 20.83%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 7 people, 29.17%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 6 people, 25.00%
Gastric Ulcer (stomach ulcer): 5 people, 20.83%
Adverse Drug Reaction: 4 people, 16.67%
High Blood Pressure: 4 people, 16.67%
Salivary Hypersecretion (excess saliva secretion): 3 people, 12.50%
Parkinson's Disease: 2 people, 8.33%
Urinary Tract Infection: 2 people, 8.33%
Stress And Anxiety: 1 person, 4.17%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Gaviscon and have Psychotic disorder?

- Check whether Psychotic disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gaviscon:

Gaviscon (12,355 reports)

Psychotic disorder treatments and more:

Psychotic disorder (61,342 reports)

How severe was Psychotic disorder and when was it recovered:

Psychotic disorder in Gaviscon

Expand to all the drugs that have ingredients of aluminum hydroxide; magnesium trisilicate:

Psychotic disorder and drugs with ingredients of aluminum hydroxide; magnesium trisilicate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psychotic disorder:

Psychotic disorder (1,230 drugs)

Browse all the conditions that are associated with Psychotic disorder:

Psychotic disorder (1,473 conditions)

Related publications that referenced our studies

Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on aluminum hydroxide; magnesium trisilicate (the active ingredients of Gaviscon) and Gaviscon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.